Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat-containing protein 48 (WDR48) is a scaffold protein characterized by multiple WD-repeat motifs forming a beta propeller structure. It primarily functions to regulate and activate deubiquitinase complexes, notably USP1, USP12, and USP46, by binding to these enzymes and facilitating their activity. WDR48 plays a central role in DNA repair through modulation of FANCD2 deubiquitination, and it promotes homologous recombination in conjunction with RAD51AP1. Through its regulatory actions, it is implicated in cancer biology (tumor suppression via PHLPP1 stabilization) and neurodegenerative disease (via genetic mutations). WDR48 is not known to be targeted directly by approved drugs, though it modulates pathways essential for genome stability and cell signaling.
Activation of deubiquitinases such as USP1, USP12, USP46 by direct binding and inducing conformational changes to enhance enzyme activity; Stimulation of deubiquitination processes involved in DNA repair and signaling pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat-containing protein 48 (WDR48).